These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27846419)

  • 1. Exclusion of participants based on substance use status: Findings from randomized controlled trials of treatments for PTSD.
    Leeman RF; Hefner K; Frohe T; Murray A; Rosenheck RA; Watts BV; Sofuoglu M
    Behav Res Ther; 2017 Feb; 89():33-40. PubMed ID: 27846419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No Wrong Doors: Findings from a Critical Review of Behavioral Randomized Clinical Trials for Individuals with Co-Occurring Alcohol/Drug Problems and Posttraumatic Stress Disorder.
    Simpson TL; Lehavot K; Petrakis IL
    Alcohol Clin Exp Res; 2017 Apr; 41(4):681-702. PubMed ID: 28055143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes?
    Jeffirs SM; Jarnecke AM; Flanagan JC; Killeen TK; Laffey TF; Back SE
    Drug Alcohol Depend; 2019 Jun; 199():70-75. PubMed ID: 31009834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-morbid post-traumatic stress disorder in a substance misusing clinical population.
    Reynolds M; Mezey G; Chapman M; Wheeler M; Drummond C; Baldacchino A
    Drug Alcohol Depend; 2005 Mar; 77(3):251-8. PubMed ID: 15734225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helping vulnerable populations: a comprehensive review of the treatment outcome literature on substance use disorder and PTSD.
    Najavits LM; Hien D
    J Clin Psychol; 2013 May; 69(5):433-79. PubMed ID: 23592045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion and exclusion criteria in randomized controlled trials of psychotherapy for PTSD.
    Ronconi JM; Shiner B; Watts BV
    J Psychiatr Pract; 2014 Jan; 20(1):25-37. PubMed ID: 24419308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating posttraumatic stress disorder in substance use disorder patients with co-occurring posttraumatic stress disorder: study protocol for a randomized controlled trial to compare the effectiveness of different types and timings of treatment.
    Lortye SA; Will JP; Marquenie LA; Goudriaan AE; Arntz A; de Waal MM
    BMC Psychiatry; 2021 Sep; 21(1):442. PubMed ID: 34493253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological treatment of PTSD with comorbid substance use disorder (SUD): expert recommendations of the European Society for Traumatic Stress Studies (ESTSS).
    Roberts NP; Lotzin A; Schäfer I
    Eur J Psychotraumatol; 2023; 14(2):2265773. PubMed ID: 37830207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial.
    Ruglass LM; Lopez-Castro T; Papini S; Killeen T; Back SE; Hien DA
    Psychother Psychosom; 2017; 86(3):150-161. PubMed ID: 28490022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttraumatic stress disorder and substance use disorder comorbidity among individuals with physical disabilities: findings from the National Comorbidity Survey Replication.
    Anderson ML; Ziedonis DM; Najavits LM
    J Trauma Stress; 2014 Apr; 27(2):182-91. PubMed ID: 24659557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel, integrated cognitive-behavioral therapy for co-occurring posttraumatic stress and substance use disorders: A pilot randomized clinical trial.
    Vujanovic AA; Smith LJ; Green CE; Lane SD; Schmitz JM
    Contemp Clin Trials; 2018 Feb; 65():123-129. PubMed ID: 29287668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lagged effects of substance use on PTSD severity in a randomized controlled trial with modified prolonged exposure and relapse prevention.
    Hien DA; Smith KZ; Owens M; López-Castro T; Ruglass LM; Papini S
    J Consult Clin Psychol; 2018 Oct; 86(10):810-819. PubMed ID: 30265040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of trauma-focused and non-trauma-focused psychotherapy for PTSD among veterans with comorbid substance use disorders: Protocol & rationale for a randomized clinical trial.
    Kehle-Forbes SM; Nelson D; Norman SB; Schnurr PP; Shea MT; Ackland PE; Meis L; Possemato K; Polusny MA; Oslin D; Hamblen JL; Galovski T; Kenny M; Babajide N; Hagedorn H
    Contemp Clin Trials; 2022 Sep; 120():106876. PubMed ID: 35987487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure therapy for substance abusers with PTSD: translating research to practice.
    Coffey SF; Schumacher JA; Brimo ML; Brady KT
    Behav Modif; 2005 Jan; 29(1):10-38. PubMed ID: 15557477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale, design, and implementation of a clinical trial of a mindfulness-based relapse prevention protocol for the treatment of women with comorbid post traumatic stress disorder and substance use disorder.
    Vrana C; Killeen T; Brant V; Mastrogiovanni J; Baker NL
    Contemp Clin Trials; 2017 Oct; 61():108-114. PubMed ID: 28765006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of substance use disorders: Effects on patients with higher or lower levels of PTSD symptoms.
    Wieferink CEM; de Haan HA; Dijkstra BAG; Fledderus M; Kok T
    Addict Behav; 2017 Nov; 74():122-126. PubMed ID: 28622616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity of PTSD, Major Depression, and Substance Use Disorder Among Adolescent Victims of the Spring 2011 Tornadoes in Alabama and Joplin, Missouri.
    Adams ZW; Danielson CK; Sumner JA; McCauley JL; Cohen JR; Ruggiero KJ
    Psychiatry; 2015; 78(2):170-85. PubMed ID: 26168094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example.
    Hien DA; Campbell AN; Ruglass LM; Saavedra L; Mathews AG; Kiriakos G; Morgan-Lopez A
    J Subst Abuse Treat; 2015 Sep; 56():23-33. PubMed ID: 25907849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnoracial differences in treatment-seeking veterans with substance use disorders and co-occurring PTSD: Presenting characteristics and response to integrated exposure-based treatment.
    Brown DG; Flanagan JC; Jarnecke A; Killeen TK; Back SE
    J Ethn Subst Abuse; 2022; 21(3):1141-1164. PubMed ID: 33111647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of trauma characteristics on post-traumatic stress disorder and substance use disorder outcomes across integrated and substance use treatments.
    Fitzpatrick S; Saraiya T; Lopez-Castro T; Ruglass LM; Hien D
    J Subst Abuse Treat; 2020 Jun; 113():107976. PubMed ID: 32059924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.